Supported in part by the Joseph and Marilyn Rosen Research Fund of the New York Glaucoma Research Institute, New York, New York, and by National Institutes of Health grants EY-02115 (DCH) and EY-025253 (CGDM).
Disclosure: M.D. Eguia, None; E. Tsamis, Topcon, Inc. (R); Z.Z. Zemborain, None; A. Sun, None; J. Percival, None; C.G. De Moraes, Belite (C), Galimedix (C), Reichert (C), Perfuse Therapeutics (C), Heidelberg Engineering (R), Novartis (C), Carl Zeiss (C), Topcon, Inc. (R), Research to Prevent Blindness (R), National Institutes of Health (R); R. Ritch, None; D.C. Hood, Heidelberg Engineering (F), Topcon, Inc. (R, F), Novartis (C, F)